Catalyst Pharmaceuticals, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
CPRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
355 Alhambra Circle, Suite 801, Coral Gables, FL

Insiders trading volume in the past year

Catalyst Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard J. Daly President and CEO, Director $52.1M -$277K -0.53% Nov 21, 2024
Patrick J. Mcenany Director, Chairman of Board of Directors $25.3M -$18.2M -41.8% Dec 9, 2024
Jeffrey Del Chief Commercial Officer $22M -$785K -3.45% Dec 9, 2024
Preethi Sundaram Chief Strategy Officer $16.6M Dec 9, 2024
Donald A. Denkhaus Director $14.8M Dec 9, 2024
Steve Miller Chief Op. & Scientific Officer $11.1M -$4.15M -27.3% Dec 13, 2024
Michael W. Kalb Executive Vice President & CFO $10.2M Nov 21, 2024
Charles B. O'Keeffe Director $8.67M Dec 9, 2024
Brian Elsbernd Chief Compliance/Legal Officer $5.07M -$698K -12.1% Dec 9, 2024
Gary Ingenito Chief Med. & Reg. Officer $4.37M -$4.18M -48.9% Dec 9, 2024
David S. Tierney Director $2.26M -$693K -23.5% Dec 9, 2024
Alicia Grande VP, Treasurer and CFO $1.4M Dec 27, 2023
Molly Harper Director $537K -$472K -46.8% Dec 9, 2024
Tamar Thompson Director $400K Dec 9, 2024
Philip H. Coelho Director $232K May 4, 2023

Recent Insider Transactions by Companies or Individuals for Catalyst Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.